Latest Updates from the ESMO Conference 2008

posted Dec 16 2008
We would like to thank Dr Ron Burkes for providing us with the latest lung oncology conference updates

ESMO Conference Updates

BO 17704 (AVAIL): A Phase III Randomised Study of First-line Bevacizumab Combined with Cisplatin/Gemcitabine (CG) in Patients (PTS) with Advanced or Recurrent Non-Squamous, Non-small Cell Lung Cancer (NSCLC)

Phase III Randomised Open-Label First-Line Study of Gefitinib (G) vs Carboplatin/Paclitaxel (C/P) in Clinically Selected Patients (PTS) with Advanced (Stage IIIB/IV) NSCLC (IPASS – Iressa Pan ASia Study)

Lung Journal Article Updates

posted Dec 4, 2008
We would like to thank Dr Charles Butts for providing us with the latest lung journal article updates

Article Reviews

Article Review: Gefitinib Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer (INTEREST): A randomised phase III trial
Original Authors: E Kim et al
Citation: Lancet. November 22 2008; 372(9652):1809-1818
Article: Journal | Pubmed